2-(2-cyclopropyl-2-oxoethyl)-N-[1-[6-(2,2-difluoroethoxy)-2-methoxy-3-pyridinyl]ethyl]pyrimidine-4-carboxamide
C20H22F2N4O4 — CID 158050802
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-(2-cyclopropyl-2-oxoethyl)-N-[1-[6-(2,2-difluoroethoxy)-2-methoxy-3-pyridinyl]ethyl]pyrimidine-4-carboxamide
2-(2-cyclopropyl-2-oxoethyl)-N-[1-[6-(2,2-difluoroethoxy)-2-methoxy-3-pyridinyl]ethyl]pyrimidine-4-carboxamide (PubChem CID 158050802) has the molecular formula C20H22F2N4O4 and a molecular weight of 420.42 g/mol. Its IUPAC name is 2-(2-cyclopropyl-2-oxoethyl)-N-[1-[6-(2,2-difluoroethoxy)-2-methoxy-3-pyridinyl]ethyl]pyrimidine-4-carboxamide.
Molecular Properties
| Compound Name | 2-(2-cyclopropyl-2-oxoethyl)-N-[1-[6-(2,2-difluoroethoxy)-2-methoxy-3-pyridinyl]ethyl]pyrimidine-4-carboxamide |
|---|---|
| PubChem CID | 158050802 |
| Molecular Formula | C20H22F2N4O4 |
| Molecular Weight | 420.42 g/mol |
| Exact Mass | 420.16 |
| IUPAC Name | 2-(2-cyclopropyl-2-oxoethyl)-N-[1-[6-(2,2-difluoroethoxy)-2-methoxy-3-pyridinyl]ethyl]pyrimidine-4-carboxamide |
| SMILES | COc1nc(OCC(F)F)ccc1C(C)NC(=O)c1ccnc(CC(=O)C2CC2)n1 |
| InChI | InChI=1S/C20H22F2N4O4/c1-11(13-5-6-18(26-20(13)29-2)30-10-16(21)22)24-19(28)14-7-8-23-17(25-14)9-15(27)12-3-4-12/h5-8,11-12,16H,3-4,9-10H2,1-2H3,(H,24,28) |
| InChIKey | FJLNVLHWBOLRNM-UHFFFAOYSA-N |
| XLogP | 2.54 |
| TPSA | 103.30 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 420.42 |
| LogP ≤ 5 | 2.54 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158050802 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.